IFCC Executive Board: 2012-2014 Biographies
Prof. Howard MORRIS, Vice President
Vice President
Professor Howard Morris
Division of Health Science
Health Sciences Divisional Office
City East Campus
Tel: +61 8 830 21029
Fax:+61 8 830 22389
Email:Howard.Morris@unisa.edu.au
Howard Morris (PhD, FAACB, FFSc(RCPA)) holds a
joint appointment as Professor of Medical Science in the School of
Pharmacy and Medical Sciences, University of South Australia and a
Chief Medical Scientist in Chemical Pathology at SA Pathology,
Adelaide Australia. Between 2003 and 2008 he was the Secretary of
the Scientific Division of the IFCC and has served as a member of
the IFCC Task Force on the Global Campaign on Diabetes Mellitus
(2003-2008), Task Force on International Clinical Liaison
(2009-2011) and International Scientific Committee XXIst
International Congress of Clinical Chemistry and Laboratory
Medicine, Berlin Germany, 2011 (2007-2011). Within the Asia Pacific
Federation of Clinical Biochemistry (APFCB) he served as Chair,
Scientific Committee (2002-2004) and Chair, Scientific Organising
Committee, Member Organising Committee for 10th Asian
Pacific Congress of Clinical Biochemistry (2002-2005). He was the
Australasian Association of Clinical Biochemists (AACB)
representative to the Councils of the IFCC and APFCB (1998-2004),
served on AACB Council (1998-2002) and Editor of the Clinical
Biochemist Reviews (1994-2002). He was awarded an AACB Outstanding
Service Medallion (2003) and the W. Roman Travelling Lectureship
(2004).
Dr Morris currently services as a Clinical Scientist for the
Chemical Pathology Directorate, SA Pathology providing clinical
advice and comments in the discipline. He had 24 years experience
working in diagnostic clinical biochemistry in the field of
immunoassay and endocrinology between 1976 and 2000 during which he
managed a major clinical endocrinology laboratory for the Institute
of Medical and Veterinary Science (IMVS, Adelaide) providing
services for the Royal Adelaide Hospital (RAH) and the state of
South Australia. In 1997/98, the laboratory reported some 245,000
patient results. Between 2003 and 2009 he was the Director of the
Hanson Institute, the research arm of the IMVS and RAH. In
2009 the Hanson Institute administered infrastructure to support
the research of some 300 staff and 100 postgraduate students who
generated external grants amounting to approximately $AUD 30
million annually.
Dr Morris leads an active research team publishing 242 refereed
publications, reviews and book chapters and being awarded over $7
million in competitive research grants. His research investigates
the pathophysiology of metabolic bone disease and the effects of
hormones including vitamin D funded by the National Health and
Medical Research Council and Australian Research Council, the major
competitive funding bodies in Australia. His latest work has
identified the basis for vitamin D requirement to reduce the risk
of fractures amongst the elderly. He was invited to present the
Louis Avioli Memorial Lecture at the 2009 Annual Scientific Meeting
of the American Society for Bone and Mineral Research on this
topic. He is also Deputy Chair of a South Australian Department of
Health Working Party on Osteoporosis and Fracture Prevention.